The Intel 15 billion share sale leverages a massive stock surge to raise capital for chip manufacturing and foundry expansion plans.
Intel announced on Monday plans to raise $15 billion through a common stock offering, capitalizing on a strong share rally driven by its turnaround strategy. The capital injection is earmarked to fund the massive, capital-intensive expansion of its contract chip manufacturing business (Intel Foundry) as it seeks to directly challenge industry titan TSMC.
Intel’s stock fell over 4% in premarket trading as investors reacted to potential equity dilution from the massive offering. Despite the pull-back, the stock has nearly tripled this year, outperforming rivals AMD and TSMC as well as the broader Philadelphia Semiconductor Index’s ~75% gain. Wall Street analysts noted that Intel’s recent share surge provided an ideal window to raise equity capital for its costly manufacturing expansion.
The rapid transition toward agentic AI has ignited renewed demand for central processing units (CPUs). Unlike traditional AI training, autonomous AI agents require heavy CPU-driven orchestration, driving customer orders past Intel’s current manufacturing capacity.
See also: Google Allows Alternative Store Aptoide Games Directly onto US Play Store
This surging demand prompted Intel to raise its 2026 capital expenditure forecast from $18 billion to over $20 billion in July. The company also committed to high-volume manufacturing on its next-generation 14A process node by 2028 a technology it previously threatened to shelve without a major external customer. Intel Foundry has already secured Tesla as a 14A customer, while speculation around a potential Apple deal grew after U.S. President Donald Trump claimed Apple would manufacture processors with Intel, though neither firm has confirmed the partnership.
A major pillar of Intel’s capital strategy is a €5 billion ($5.77 billion) investment to expand and upgrade its chip manufacturing facilities in Leixlip, Ireland a project accounting for over 25% of its planned 2026 capital budget. To facilitate the equity raise, Intel will grant underwriters a 30-day option to purchase up to an additional $2.25 billion in shares. JPMorgan Securities, Goldman Sachs, Morgan Stanley, and Citigroup Global Markets are serving as joint book-running managers for the offering.
